Diagnostic error as a result of drug-laboratory test interactions

Jasmijn A. van Balveren (Corresponding Author), Wilhelmine P.H.G. Verboeket-van de Venne, Lale Erdem-Eraslan, Albert J. de Graaf, Annemarieke E. Loot, Ruben E.A. Musson, Wytze P. Oosterhuis, Martin P. Schuijt, Heleen van der Sijs, Rolf J. Verheul, Holger K. de Wolf, Ron Kusters, Rein M.J. Hoedemakers,

Research output: Contribution to journalReview articleAcademicpeer-review

2 Downloads (Pure)

Abstract

Background Knowledge of possible drug-laboratory test interactions (DLTIs) is important for the interpretation of laboratory test results. Test results may be affected by physiological or analytical drug effects. Failure to recognize these interactions may lead to misinterpretation of test results, a delayed or erroneous diagnosis or unnecessary extra tests or therapy, which may harm patients. Content Thousands of interactions have been reported in the literature, but are often fragmentarily described and some papers even reported contradictory findings. How can healthcare professionals become aware of all these possible interactions in their individual patients? DLTI decision support applications could be a good solution. In a literature search, only four relevant studies have been found on DLTI decision support applications in clinical practice. These studies show a potential benefit of automated DLTI messages to physicians for the interpretation of laboratory test results. All physicians reported that part of the DLTI messages were useful. In one study, 74% of physicians even sometimes refrained from further additional examination. Summary and outlook Unrecognized DLTIs potentially cause diagnostic errors in a large number of patients. Therefore, efforts to avoid these errors, for example with a DLTI decision support application, could tremendously improve patient outcome.

Original languageEnglish
Pages (from-to)69-71
Number of pages3
JournalDiagnosis (Berlin, Germany)
Volume6
Issue number1
DOIs
Publication statusPublished - 26 Mar 2019

Fingerprint

Diagnostic Errors
Pharmaceutical Preparations
Physicians
Patient Harm
Delivery of Health Care

Keywords

  • (computerized) clinical decision support
  • clinical laboratory test
  • diagnostic error
  • drug-laboratory test interaction
  • patient safety

Cite this

van Balveren, J. A., Verboeket-van de Venne, W. P. H. G., Erdem-Eraslan, L., de Graaf, A. J., Loot, A. E., Musson, R. E. A. (2019). Diagnostic error as a result of drug-laboratory test interactions. Diagnosis (Berlin, Germany), 6(1), 69-71. https://doi.org/10.1515/dx-2018-0098
van Balveren, Jasmijn A. ; Verboeket-van de Venne, Wilhelmine P.H.G. ; Erdem-Eraslan, Lale ; de Graaf, Albert J. ; Loot, Annemarieke E. ; Musson, Ruben E.A. ; Oosterhuis, Wytze P. ; Schuijt, Martin P. ; van der Sijs, Heleen ; Verheul, Rolf J. ; de Wolf, Holger K. ; Kusters, Ron ; Hoedemakers, Rein M.J. / Diagnostic error as a result of drug-laboratory test interactions. In: Diagnosis (Berlin, Germany). 2019 ; Vol. 6, No. 1. pp. 69-71.
@article{7d8aff1816924ed5a31834a1d8066f25,
title = "Diagnostic error as a result of drug-laboratory test interactions",
abstract = "Background Knowledge of possible drug-laboratory test interactions (DLTIs) is important for the interpretation of laboratory test results. Test results may be affected by physiological or analytical drug effects. Failure to recognize these interactions may lead to misinterpretation of test results, a delayed or erroneous diagnosis or unnecessary extra tests or therapy, which may harm patients. Content Thousands of interactions have been reported in the literature, but are often fragmentarily described and some papers even reported contradictory findings. How can healthcare professionals become aware of all these possible interactions in their individual patients? DLTI decision support applications could be a good solution. In a literature search, only four relevant studies have been found on DLTI decision support applications in clinical practice. These studies show a potential benefit of automated DLTI messages to physicians for the interpretation of laboratory test results. All physicians reported that part of the DLTI messages were useful. In one study, 74{\%} of physicians even sometimes refrained from further additional examination. Summary and outlook Unrecognized DLTIs potentially cause diagnostic errors in a large number of patients. Therefore, efforts to avoid these errors, for example with a DLTI decision support application, could tremendously improve patient outcome.",
keywords = "(computerized) clinical decision support, clinical laboratory test, diagnostic error, drug-laboratory test interaction, patient safety",
author = "{van Balveren}, {Jasmijn A.} and {Verboeket-van de Venne}, {Wilhelmine P.H.G.} and Lale Erdem-Eraslan and {de Graaf}, {Albert J.} and Loot, {Annemarieke E.} and Musson, {Ruben E.A.} and Oosterhuis, {Wytze P.} and Schuijt, {Martin P.} and {van der Sijs}, Heleen and Verheul, {Rolf J.} and {de Wolf}, {Holger K.} and Ron Kusters and Hoedemakers, {Rein M.J.}",
year = "2019",
month = "3",
day = "26",
doi = "10.1515/dx-2018-0098",
language = "English",
volume = "6",
pages = "69--71",
journal = "Diagnosis",
issn = "2194-8011",
publisher = "Walter De Gruyter",
number = "1",

}

van Balveren, JA, Verboeket-van de Venne, WPHG, Erdem-Eraslan, L, de Graaf, AJ, Loot, AE, Musson, REA, Oosterhuis, WP, Schuijt, MP, van der Sijs, H, Verheul, RJ, de Wolf, HK, Kusters, R, Hoedemakers, RMJ 2019, 'Diagnostic error as a result of drug-laboratory test interactions' Diagnosis (Berlin, Germany), vol. 6, no. 1, pp. 69-71. https://doi.org/10.1515/dx-2018-0098

Diagnostic error as a result of drug-laboratory test interactions. / van Balveren, Jasmijn A. (Corresponding Author); Verboeket-van de Venne, Wilhelmine P.H.G.; Erdem-Eraslan, Lale; de Graaf, Albert J.; Loot, Annemarieke E.; Musson, Ruben E.A.; Oosterhuis, Wytze P.; Schuijt, Martin P.; van der Sijs, Heleen; Verheul, Rolf J.; de Wolf, Holger K.; Kusters, Ron; Hoedemakers, Rein M.J.

In: Diagnosis (Berlin, Germany), Vol. 6, No. 1, 26.03.2019, p. 69-71.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Diagnostic error as a result of drug-laboratory test interactions

AU - van Balveren, Jasmijn A.

AU - Verboeket-van de Venne, Wilhelmine P.H.G.

AU - Erdem-Eraslan, Lale

AU - de Graaf, Albert J.

AU - Loot, Annemarieke E.

AU - Musson, Ruben E.A.

AU - Oosterhuis, Wytze P.

AU - Schuijt, Martin P.

AU - van der Sijs, Heleen

AU - Verheul, Rolf J.

AU - de Wolf, Holger K.

AU - Kusters, Ron

AU - Hoedemakers, Rein M.J.

PY - 2019/3/26

Y1 - 2019/3/26

N2 - Background Knowledge of possible drug-laboratory test interactions (DLTIs) is important for the interpretation of laboratory test results. Test results may be affected by physiological or analytical drug effects. Failure to recognize these interactions may lead to misinterpretation of test results, a delayed or erroneous diagnosis or unnecessary extra tests or therapy, which may harm patients. Content Thousands of interactions have been reported in the literature, but are often fragmentarily described and some papers even reported contradictory findings. How can healthcare professionals become aware of all these possible interactions in their individual patients? DLTI decision support applications could be a good solution. In a literature search, only four relevant studies have been found on DLTI decision support applications in clinical practice. These studies show a potential benefit of automated DLTI messages to physicians for the interpretation of laboratory test results. All physicians reported that part of the DLTI messages were useful. In one study, 74% of physicians even sometimes refrained from further additional examination. Summary and outlook Unrecognized DLTIs potentially cause diagnostic errors in a large number of patients. Therefore, efforts to avoid these errors, for example with a DLTI decision support application, could tremendously improve patient outcome.

AB - Background Knowledge of possible drug-laboratory test interactions (DLTIs) is important for the interpretation of laboratory test results. Test results may be affected by physiological or analytical drug effects. Failure to recognize these interactions may lead to misinterpretation of test results, a delayed or erroneous diagnosis or unnecessary extra tests or therapy, which may harm patients. Content Thousands of interactions have been reported in the literature, but are often fragmentarily described and some papers even reported contradictory findings. How can healthcare professionals become aware of all these possible interactions in their individual patients? DLTI decision support applications could be a good solution. In a literature search, only four relevant studies have been found on DLTI decision support applications in clinical practice. These studies show a potential benefit of automated DLTI messages to physicians for the interpretation of laboratory test results. All physicians reported that part of the DLTI messages were useful. In one study, 74% of physicians even sometimes refrained from further additional examination. Summary and outlook Unrecognized DLTIs potentially cause diagnostic errors in a large number of patients. Therefore, efforts to avoid these errors, for example with a DLTI decision support application, could tremendously improve patient outcome.

KW - (computerized) clinical decision support

KW - clinical laboratory test

KW - diagnostic error

KW - drug-laboratory test interaction

KW - patient safety

UR - http://www.scopus.com/inward/record.url?scp=85062052057&partnerID=8YFLogxK

U2 - 10.1515/dx-2018-0098

DO - 10.1515/dx-2018-0098

M3 - Review article

VL - 6

SP - 69

EP - 71

JO - Diagnosis

JF - Diagnosis

SN - 2194-8011

IS - 1

ER -

van Balveren JA, Verboeket-van de Venne WPHG, Erdem-Eraslan L, de Graaf AJ, Loot AE, Musson REA et al. Diagnostic error as a result of drug-laboratory test interactions. Diagnosis (Berlin, Germany). 2019 Mar 26;6(1):69-71. https://doi.org/10.1515/dx-2018-0098